Cargando…
Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
Since the discovery of the causal association between human papillomavirus (HPV) and cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV infections have been at the forefront of modern medical research. HPV causes 530,000 cervical cancer cases worldwide, wh...
Autores principales: | Kash, Natalie, Lee, Michael A., Kollipara, Ramya, Downing, Christopher, Guidry, Jacqueline, Tyring, Stephen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470159/ https://www.ncbi.nlm.nih.gov/pubmed/26239350 http://dx.doi.org/10.3390/jcm4040614 |
Ejemplares similares
-
Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV
por: Kollipara, Ramya, et al.
Publicado: (2015) -
HPV Carcinomas in Immunocompromised Patients
por: Reusser, Nicole M., et al.
Publicado: (2015) -
Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients
por: Chockalingam, Ramya, et al.
Publicado: (2015) -
Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023) -
Verrucous sarcoidosis associated with human papillomavirus infection: A case report
por: Noparstak, Michael, et al.
Publicado: (2015)